-+ 0.00%
-+ 0.00%
-+ 0.00%

Biogen To Host Investor Seminar At 10:00 a.m. ET Focused On Potential Of Felzartamab In Immune-Mediated Diseases

Benzinga·06/11/2025 12:39:08
Listen to the news

Immune-Mediated Diseases